Tag: Galcanezumab

Neurology

Galcanezumab Cuts Frequency of Disabling Cluster Headaches

Newsemia
Galcanezumab is a welcome option for patients who have grown frustrated with currently available treatment options, one headache expert said. Medscape Medical News Source link...
Neurology

FDA Greenlights Galcanezumab (Emgality) for Migraine Prevention

Newsemia
On the heels of recent approvals for two other calcitonin gene-related peptide (CGRP) antagonists for the prevention of migraine in adults, the FDA has approved...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World